New program aims to close racial gap in liver cancer care

NCT ID NCT06728293

Recruiting now Disease control Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a culturally tailored support program for Black patients with early-stage liver cancer. The program includes education, help with social needs, and easier access to cancer specialists. Forty participants will be randomly assigned to the program or usual care and followed for six months to see if they get curative treatments faster.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Liver Link support program (patient education, social needs screening, and facilitated cancer care access)
What this could lead to: If successful, this program could help reduce racial disparities in liver cancer treatment and improve access to life-saving therapies for Black patients.
What could go wrong: This is a small pilot study with only 40 participants, so results may not apply broadly. The program may not significantly speed up treatment or improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HCC RACIAL DISPARITIES

Contacts and locations

Locations

Indiana University School of Medicine
RECRUITING

Indianapolis, Indiana, 46202, United States
Johns Hopkins University
RECRUITING

Baltimore, Maryland, 21218, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.